Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.
Strasser-Weippl K, Horick N, Smith IE, O'Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE. Strasser-Weippl K, et al. Eur J Cancer. 2016 Mar;56:85-92. doi: 10.1016/j.ejca.2015.12.024. Epub 2016 Jan 30. Eur J Cancer. 2016. PMID: 26829011 Clinical Trial.
Aromatase inhibitors for chemoprevention.
Goss PE, Strasser-Weippl K. Goss PE, et al. Best Pract Res Clin Endocrinol Metab. 2004 Mar;18(1):113-30. doi: 10.1016/s1521-690x(03)00070-8. Best Pract Res Clin Endocrinol Metab. 2004. PMID: 14687601 Review.
Prevention strategies with aromatase inhibitors.
Goss PE, Strasser-Weippl K. Goss PE, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):372S-9S. doi: 10.1158/1078-0432.ccr-031210. Clin Cancer Res. 2004. PMID: 14734494
Planning cancer control in Latin America and the Caribbean.
Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St Louis J, Villarreal-Garza C, Unger-Saldaña K, Ferreyra M, Debiasi M, Liedke PE, Touya D, Werutsky G, Higgins M, Fan L, Vasconcelos C, Cazap E, Vallejos C, Mohar A, Knaul F, Arreola H, Batura R, Luciani S, Sullivan R, Finkelstein D, Simon S, Barrios C, Kightlinger R, Gelrud A, Bychkovsky V, Lopes G, Stefani S, Blaya M, Souza FH, Santos FS, Kaemmerer A, de Azambuja E, Zorilla AF, Murillo R, Jeronimo J, Tsu V, Carvalho A, Gil CF, Sternberg C, Dueñas-Gonzalez A, Sgroi D, Cuello M, Fresco R, Reis RM, Masera G, Gabús R, Ribeiro R, Knust R, Ismael G, Rosenblatt E, Roth B, Villa L, Solares AL, Leon MX, Torres-Vigil I, Covarrubias-Gomez A, Hernández A, Bertolino M, Schwartsmann G, Santillana S, Esteva F, Fein L, Mano M, Gomez H, Hurlbert M, Durstine A, Azenha G. Goss PE, et al. Lancet Oncol. 2013 Apr;14(5):391-436. doi: 10.1016/S1470-2045(13)70048-2. Lancet Oncol. 2013. PMID: 23628188
Competing risks in low-risk breast cancer.
Strasser-Weippl K, Goss PE. Strasser-Weippl K, et al. Am Soc Clin Oncol Educ Book. 2013:32-9. doi: 10.14694/EdBook_AM.2013.33.32. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714449 Free article.
44 results